In vitro mutagenic, antimutagenic, and antioxidant activities evaluation and biotransformation of some bioactive 4‐substituted 1‐(2‐methoxyphenyl)piperazine derivatives. Issue 12 (24th July 2016)

• Record Type: Journal Article
• Authors: Słoczyńska, Karolina; Pańczyk, Katarzyna; Waszkielewicz, Anna M.; Marona, Henryk; Pękala, Elżbieta
• Is Part Of: Journal of biochemical and molecular toxicology. Volume 30:Issue 12(2016:Dec.)
• Page Start: 593
• Page End: 601
• Publication Date: 2016-07-24
• Subjects: Ames test -- antimutagenicity -- biotransformation -- mutagenicity -- piperazine derivatives; Biochemistry -- Periodicals; Molecular biology -- Periodicals; Toxicology -- Periodicals; 574
• DOI: 10.1002/jbt.21826
• Languages: English
• ISSNs: 1095-6670

Abstract

Abstract: In vitro mutagenic, antimutagenic, and antioxidant potency evaluation and biotransformation of six novel 4‐substituted 1‐(2‐methoxyphenyl)piperazine derivatives demonstrating antidepressant‐like activity were investigated. Mutagenic and antimutagenic properties were assessed using the Ames test; free radical scavenging activity was evaluated with 2, 2‐diphenyl‐1‐picrylhydrazyl radical scavenging assay and biotransformation was performed with liver microsomes. It was found that all tested compounds are not mutagenic in bacterial strains TA100 and TA1535 and exhibit antimutagenic effects in the Ames test. Noteworthy, compounds possessing propyl linker between phenoxyl and N ‐(2‐methoxyphenyl)piperazine displayed more pronounced antimutagenic properties than derivatives with ethoxyethyl linker. Additionally, compounds 2 and 6 in vitro biotransformation showed that primarily their hydroxylated or O ‐dealkylated metabolites are formed. Some of the compounds exhibited intrinsic clearance values lower than those reported previously for antidepressant imipramine. To sum up, the results of the present study might represent a valuable step in designing and planning future studies with piperazine derivatives.